Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético

Gonzalez-Porras, JR; Mingot-Castellano, ME; Andrade, MM; Alonso, R; Caparros, I; Arratibel, MC; Fernandez-Fuertes, F; Cortti, MJ; Pascual, C; Sanchez-Gonzalez, B; Bernat, S; Fuertes-Palacio, MA; Vazquez-Paganini, JA; Olivera, PE; Alvarez-Roman, MT; Jarque, I; Cortes, M; Martinez-Robles, V; Diaz-Galvez, FJ; Calbacho, M; Fernandez-Minano, C; Garcia-Frade, J; Gonzalez-Lopez, TJ.

Use of eltrombopag after romiplostim in primary immune thrombocytopenia

BRITISH JOURNAL OF HAEMATOLOGY. 2015; 169(1): 111-116 Nº de citas: 62 [doi:10.1111/bjh.13266]

Martino, R; Bautista, G; Parody, R; Garcia, I; Esquirol, A; Rovira, M; Cabrera, JR; Regidor, C; Fores, R; Garcia-Marco, JA; Serrano, D; Barba, P; Heras, I; Marquez-Malaver, FJ; Sanchez-Ortega, I; Duarte, R; Saavedra, S; Sierra, J; Vazquez, L.

Severe infections after single umbilical cord blood transplantation in adults with or without the co-infusion of CD34(+) cells from a third-party donor: results of a multicenter study from the Grupo Espanol de Trasplante Hematopoyetico (GETH)

TRANSPLANT INFECTIOUS DISEASE. 2015; 17(2): 221-233 Nº de citas: 7 [doi:10.1111/tid.12361]

Ferra, C; Sanz, J; Diaz-Perez, MA; Morgades, M; Gayoso, J; Cabrera, JR; Villaescusa, T; Sampol, MA; Fernandez-Aviles, F; Solano, C; Ortin, M; Duarte, R; Cuesta, M; Heras, I; de la Serna, J; Moraleda, JM; Barrenetxea, C; Gonzalez-Vicent, M; Sanz, G; Ribera, JM.

Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients

LEUKEMIA & LYMPHOMA. 2015; 56(3): 656-662 Nº de citas: 38 [doi:10.3109/10428194.2014.930849]

Gonzalez-Lopez, TJ; Pascual, C; Alvarez-Roman, MT; Fernandez-Fuertes, F; Sanchez-Gonzalez, B; Caparros, I; Jarque, I; Mingot-Castellano, ME; Hernandez-Rivas, JA; Martin-Salces, M; Solan, L; Beneit, P; Jimenez, R; Bernat, S; Andrade, MM; Cortes, M; Cortti, MJ; Perez-Crespo, S; Gomez-Nunez, M; Olivera, PE; Perez-Rus, G; Martinez-Robles, V; Alonso, R; Fernandez-Rodriguez, A; Arratibel, MC; Perera, M; Fernandez-Minano, C; Fuertes-Palacio, MA; Vazquez-Paganini, JA; Gutierrez-Jomarron, I; Valcarce, I; de Cabo, E; Sainz, A; Fisac, R; Aguilar, C; Martinez-Badas, MP; Penarrubia, MJ; Calbacho, M; de Cos, C; Gonzalez-Silva, M; Coria, E; Alonso, A; Casaus, A; Luana, A; Galan, P; Fernandez-Canal, C; Garcia-Frade, J; Gonzalez-Porras, JR.

Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia

AMERICAN JOURNAL OF HEMATOLOGY. 2015; 90(3): 40-43 Nº de citas: 135 [doi:10.1002/ajh.23900]

Parody, R; Martino, R; de la Camara, R; Garcia-Noblejas, A; Esquirol, A; Garcia-Cadenas, I; Villaescusa, T; Caballero, D; Rovira, M; Fernandez-Aviles, F; Marquez-Malaver, FJ; Espigado, I; Castilla-Llorente, C; Heras, I; Cabero, MA; Cabrera, JR; Barba, P; Valcarcel, D; Sanchez-Ortega, I; Duarte, RF; Serrano, D; Carretero, F; Vazquez, L.

Fungal and viral infections after allogeneic hematopoietic transplantation from unrelated donors in adults: improving outcomes over time

BONE MARROW TRANSPLANTATION. 2015; 50(2): 274-281 Nº de citas: 15 [doi:10.1038/bmt.2014.229]

Martinez-Laperche, C; Noriega, V; Kwon, M; Balsalobre, P; Gonzalez-Rivera, M; Serrano, D; Anguita, J; Gayoso, J; Diez-Martin, JL; Buno, I.

Achievement of early complete donor chimerism in CD25(+)-activated leukocytes is a strong predictor of the development of graft-versus-host-disease after stem cell transplantation

EXP HEMATOL. 2015; 43(1): 4-13 Nº de citas: 4 [doi:10.1016/j.exphem.2014.09.003]

de Lorenzo-Pinto, A; Garcia-Sanchez, R; Izquierdo, CP; Duran-Garcia, ME; Castuera-Gil, AI; Andueza-Lillo, JA; Sanjurjo-Saez, M.

Impact of the endorse study results on thromboprophylaxis prescribing patterns in medical patients attending the Emergency Department

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. 2015; 69(1): 81-86 Nº de citas: 2 [doi:10.1111/ijcp.12461]

Gonzalez-Lopez, TJ; Sanchez-Gonzalez, B; Pascual, C; Arefi, M; de Cabo, E; Alonso, A; Martin-Salces, M; Jimenez-Barcenas, R; Calbacho, M; Galan, P; Barez, A; Gonzalez-Porras, JR.

Sustained response after discontinuation of short-and medium-term treatment with eltrombopag in patients with immune thrombocytopenia

PLATELETS. 2015; 26(1): 83-86 Nº de citas: 15 [doi:10.3109/09537104.2013.870987]

Kwon, M; Bautista, G; Balsalobre, P; Sanchez-Ortega, I; Serrano, D; Anguita, J; Buno, I; Fores, R; Regidor, C; Marco, JAG; Vilches, C; de Pablo, R; Fernandez, MN; Gayoso, J; Duarte, R; Diez-Martin, JL; Cabrera, R.

Haplo-Cord Transplantation Using CD34(+) Cells from a Third-Party Donor to Speed Engraftment in High-Risk Patients with Hematologic Disorders

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2014; 20(12): 2015-2022 Nº de citas: 38 [doi:10.1016/j.bbmt.2014.08.024]

Martin-Sanchez, E; Odqvist, L; Rodriguez-Pinilla, SM; Sanchez-Beato, M; Roncador, G; Dominguez-Gonzalez, B; Blanco-Aparicio, C; Collazo, AMG; Cantalapiedra, EG; Fernandez, JP; del Olmo, SC; Pisonero, H; Madureira, R; Almaraz, C; Mollejo, M; Alves, FJ; Menarguez, J; Gonzalez-Palacios, F; Rodriguez-Peralto, JL; Ortiz-Romero, PL; Real, FX; Garcia, JF; Bischoff, JR; Piris, MA.

PIM Kinases as Potential Therapeutic Targets in a Subset of Peripheral T Cell Lymphoma Cases

PLoS One. 2014; 9(11): Nº de citas: 19 [doi:10.1371/journal.pone.0112148]

Escudero-Vilaplana V; Osorio Prendes S; Sanjurjo Sáez M.

Posible exantema pruriginoso secundario a lenalidomida.

FARMACIA HOSPITALARIA. 2014; 38(6): 495-496 Nº de citas: 1 [doi:10.7399/fh.2014.38.6.8176]

Garcia-Gutierrez, V; Puerta, JM; Maestro, B; Montero, LFC; Muriel, A; Hurtado, JRM; Perez-Encinas, M; Romero, MVM; Sunol, PB; Garcia, RS; De Paz, R; Sanchez, MJR; Osorio, S; Vazquez, MIM; Lopez, JM; Sastre, JL; Portero, MD; Bautista, G; Nieto, MSD; Giraldo, P; Jambrina, MJ; Burgaleta, C; Aredondo, JR; Penarrubia, MJ; Requena, MJ; Valle, MDF; Calle, C; Coll, AP; Hernandez-Rivas, JA; Osorio, RF; Cano, P; Perez, DT; de la Mata, MF; Garrido, PL; Steegmann, JL.

Do chronic myeloid leukemia patients with late "warning" responses benefit from "watch and wait" or switching therapy to a second generation tyrosine kinase inhibitor?

AMERICAN JOURNAL OF HEMATOLOGY. 2014; 89(11): 206-211 Nº de citas: 5 [doi:10.1002/ajh.23816]

García-Baró-Huarte M; Iglesias-Mohedano AM; Slöcker-Barrio M; Vázquez-López M; García-Morín M; Miranda-Herrero MC; Castro-Castro P.

Phenotypic variability in a four generation family with a p.Thr666Met CACNA1A gene mutation.

PEDIATRIC NEUROLOGY. 2014; 51(4): 557-559 Nº de citas: 11 [doi:10.1016/j.pediatrneurol.2014.07.008]

Bardon-Cancho, EJ; Munoz-Jimenez, L; Vazquez-Lopez, M; Ruiz-Martin, Y; Garcia-Morin, M; Barredo-Valderrama, E.

Periventricular Nodular Heterotopia and Dystonia Due to an ARFGEF2; Mutation

PEDIATRIC NEUROLOGY. 2014; 51(3): 461-464 Nº de citas: 17 [doi:10.1016/j.pediatrneurol.2014.05.008]

Bastos-Oreiro, M; Perez-Corral, A; Martinez-Laperche, C; Bento, L; Pascual, C; Kwon, M; Balsalobre, P; Munoz, C; Buces, E; Serrano, D; Gayoso, J; Buno, I; Anguita, J; Diez-Martin, JL.

Prognostic impact of minimal residual disease analysis by flow cytometry in patients with acute myeloid leukemia before and after allogeneic hemopoietic stem cell transplantation

EUROPEAN JOURNAL OF HAEMATOLOGY. 2014; 93(3): 239-246 Nº de citas: 64 [doi:10.1111/ejh.12336]

Logan, AC; Vashi, N; Faham, M; Carlton, V; Kong, K; Buno, I; Zheng, JB; Moorhead, M; Klinger, M; Zhang, B; Waqar, A; Zehnder, JL; Miklos, DB.

Immunoglobulin and T Cell Receptor Gene High-Throughput Sequencing Quantifies Minimal Residual Disease in Acute Lymphoblastic Leukemia and Predicts Post-Transplantation Relapse and Survival

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2014; 20(9): 1307-1313 Nº de citas: 128 [doi:10.1016/j.bbmt.2014.04.018]

Raya, JM; Montes-Moreno, S; Acevedo, A; Ferrandez, A; Fraga, M; Garcia, JF; Garcia, M; Mayordomo-Aranda, E; Menarguez, J; Besses, C; Calzada, R; Rozman, M.

Pathology reporting of bone marrow biopsy in myelofibrosis; application of the Delphi consensus process to the development of a standardised diagnostic report

JOURNAL OF CLINICAL PATHOLOGY. 2014; 67(7): 620-625 Nº de citas: 9 [doi:10.1136/jclinpath-2014-202246]

Sanchez-Garcia, J; del Canizo, C; Lorenzo, I; Nomdedeu, B; Luno, E; de Paz, R; Xicoy, B; Valcarcel, D; Brunet, S; Marco-Betes, V; Garcia-Pintos, M; Osorio, S; Tormo, M; Bailen, A; Cervero, C; Ramos, F; Diez-Campelo, M; Such, E; Arrizabalaga, B; Azaceta, G; Bargay, J; Arilla, MJ; Falantes, J; Serrano-Lopez, J; Sanz, GF.

Multivariate time-dependent comparison of the impact of lenalidomide in lower-risk myelodysplastic syndromes with chromosome 5q deletion

BRITISH JOURNAL OF HAEMATOLOGY. 2014; 166(2): 189-201 Nº de citas: 17 [doi:10.1111/bjh.12876]